NCT05865457 - Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions

Dry Eye Disease

Interventions

DEVICE

BUFY02 eye drops in single-dose containers

1 to 2 drops in each eye, as often as needed

DEVICE

TRB02 eye drops in single-dose containers

1 to 2 drops in each eye, as often as needed

Trial Locations (4)

RECRUITING

Medical University Graz, Graz

RECRUITING

VIROS, Vienna

RECRUITING

CHRU Brest, Brest

RECRUITING

CHU Nice, Nice

All Listed Sponsors

lead

TRB Chemedica International SA

INDUSTRY